New compounds show promise against breast cancer and diabetes

Researchers from Omsk State University, in collaboration with the Institute of Theoretical and Experimental Biophysics of the Russian Academy of Sciences, have proposed a new approach for designing pharmaceutical compounds with potential applications in the treatment of cancer, diabetes, and high blood pressure.

According to a university representative, chemists at Omsk State University have successfully developed a technique for synthesizing biologically active derivatives of pyridin-2-one, a class of compounds that serves as a key structural component in numerous drugs used to treat metabolic disorders, cardiovascular diseases, and various forms of cancer.

The newly developed method is based on a reaction carried out in a superbasic medium, which is capable of ionizing weak acids. This approach enables the production of targeted 4-aryl pyridin-2-one compounds with exceptionally high yields ranging from 97% to 98%.

In addition to improving production efficiency, the technique allows researchers to fine-tune the molecular architecture of the synthesized compounds by modifying reaction conditions. Such control could facilitate the targeted synthesis of molecules with specific biological properties, potentially accelerating the development of next-generation therapeutics.

To evaluate the biological activity of the newly synthesized compounds, the researchers conducted cytotoxicity assays using the human breast cancer cell line BT474. The tests revealed that several of the compounds significantly reduced the viability of cancer cells.

The study further demonstrated that the degree of cytotoxicity depended on the nature of the chemical substituents attached to the molecules. Morphological analyses confirmed that exposure to the synthesized compounds induced cell death in cancer cells, while untreated control samples remained viable.

"These developments expand the range of compounds available for biological activity studies," said Dr. Vladislav Shuvalov of the Department of Organic and Analytical Chemistry at Omsk State University. "Such fundamental knowledge may provide the basis for the development of new pharmaceutical agents."